Literature DB >> 22286501

SORL1 genetic variants and cerebrospinal fluid biomarkers of Alzheimer’s disease.

Liang-Hao Guo, Christine Westerteicher, Xin-Hui Wang, Martina Kratzer, Amalia Tsolakidou, Meizi Jiang, Timo Grimmer, Simon M Laws, Panagiotis Alexopoulos, Hideaki Bujo, Alexander Kurz, Robert Perneczky.   

Abstract

The neuronal sortilin-related receptor with A-type repeats (SORL1, also called LR11 or sorLA) is involved in amyloidogenesis, and the SORL1 gene is a major risk factor for Alzheimer’s disease (AD). We investigated AD-related CSF biomarkers for associations with SORL1 genetic variants in 105 German patients with mild cognitive impairment (MCI) and AD. The homozygous CC-allele of single nucleotide polymorphism (SNP) 4 was associated with increased Tau concentrations in AD, and the minor alleles of SNP8, SNP9, and SNP10 and the haplotype CGT of these SNPs were associated with increased SORL1 concentrations in MCI. SNP22 and SNP23, and the haplotypes TCT of SNP19-21-23, and TTC of SNP22-23-24 were correlated with decreased Ab42 levels in AD. These results strengthen the functional role of SORL1 in AD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22286501     DOI: 10.1007/s00406-012-0295-x

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  27 in total

1.  The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease.

Authors:  Ekaterina Rogaeva; Yan Meng; Joseph H Lee; Yongjun Gu; Toshitaka Kawarai; Fanggeng Zou; Taiichi Katayama; Clinton T Baldwin; Rong Cheng; Hiroshi Hasegawa; Fusheng Chen; Nobuto Shibata; Kathryn L Lunetta; Raphaelle Pardossi-Piquard; Christopher Bohm; Yosuke Wakutani; L Adrienne Cupples; Karen T Cuenco; Robert C Green; Lorenzo Pinessi; Innocenzo Rainero; Sandro Sorbi; Amalia Bruni; Ranjan Duara; Robert P Friedland; Rivka Inzelberg; Wolfgang Hampe; Hideaki Bujo; You-Qiang Song; Olav M Andersen; Thomas E Willnow; Neill Graff-Radford; Ronald C Petersen; Dennis Dickson; Sandy D Der; Paul E Fraser; Gerold Schmitt-Ulms; Steven Younkin; Richard Mayeux; Lindsay A Farrer; Peter St George-Hyslop
Journal:  Nat Genet       Date:  2007-01-14       Impact factor: 38.330

Review 2.  VPS10P-domain receptors - regulators of neuronal viability and function.

Authors:  Thomas E Willnow; Claus M Petersen; Anders Nykjaer
Journal:  Nat Rev Neurosci       Date:  2008-11-12       Impact factor: 34.870

3.  Development of an immunoassay for the quantification of soluble LR11, a circulating marker of atherosclerosis.

Authors:  Masanao Matsuo; Hiroyuki Ebinuma; Isamu Fukamachi; Meizi Jiang; Hideaki Bujo; Yasushi Saito
Journal:  Clin Chem       Date:  2009-08-06       Impact factor: 8.327

Review 4.  What's wrong with Bonferroni adjustments.

Authors:  T V Perneger
Journal:  BMJ       Date:  1998-04-18

5.  CSF BACE1 activity is increased in CJD and Alzheimer disease versus [corrected] other dementias.

Authors:  R M D Holsinger; J S Lee; A Boyd; C L Masters; S J Collins
Journal:  Neurology       Date:  2006-08-22       Impact factor: 9.910

6.  Validating predicted biological effects of Alzheimer's disease associated SNPs using CSF biomarker levels.

Authors:  John S K Kauwe; Carlos Cruchaga; Sarah Bertelsen; Kevin Mayo; Wayne Latu; Petra Nowotny; Anthony L Hinrichs; Anne M Fagan; David M Holtzman; Alison M Goate
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

7.  Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain.

Authors:  Karrie E Grear; I-Fang Ling; James F Simpson; Jennifer L Furman; Christopher R Simmons; Shawn L Peterson; Frederick A Schmitt; William R Markesbery; Qiang Liu; Julia E Crook; Steven G Younkin; Guojun Bu; Steven Estus
Journal:  Mol Neurodegener       Date:  2009-11-04       Impact factor: 14.195

8.  Sequence variation in SORL1 and dementia risk in Swedes.

Authors:  Chandra A Reynolds; Mun-Gwan Hong; Ulrika K Eriksson; Kaj Blennow; Boo Johansson; Bo Malmberg; Stig Berg; Margaret Gatz; Nancy L Pedersen; Anna M Bennet; Jonathan A Prince
Journal:  Neurogenetics       Date:  2009-08-04       Impact factor: 2.660

9.  Influence of SORL1 gene variants: association with CSF amyloid-beta products in probable Alzheimer's disease.

Authors:  Heike Kölsch; Frank Jessen; Jens Wiltfang; Piotr Lewczuk; Martin Dichgans; Johannes Kornhuber; Lutz Frölich; Isabella Heuser; Oliver Peters; Jörg B Schulz; Sibylle G Schwab; Wolfgang Maier
Journal:  Neurosci Lett       Date:  2008-05-18       Impact factor: 3.046

10.  Implication of sex and SORL1 variants in italian patients with Alzheimer disease.

Authors:  Elena Cellini; Andrea Tedde; Silvia Bagnoli; Silvia Pradella; Silvia Piacentini; Sandro Sorbi; Benedetta Nacmias
Journal:  Arch Neurol       Date:  2009-10
View more
  12 in total

Review 1.  The role of the retromer complex in aging-related neurodegeneration: a molecular and genomic review.

Authors:  Christiane Reitz
Journal:  Mol Genet Genomics       Date:  2014-10-21       Impact factor: 3.291

Review 2.  Informatics Support for Basic Research in Biomedicine.

Authors:  Thomas C Rindflesch; Catherine L Blake; Marcelo Fiszman; Halil Kilicoglu; Graciela Rosemblat; Jodi Schneider; Caroline J Zeiss
Journal:  ILAR J       Date:  2017-07-01

3.  Genetic discoveries in AD using CSF amyloid and tau.

Authors:  Carlos Cruchaga; Mark T W Ebbert; John S K Kauwe
Journal:  Curr Genet Med Rep       Date:  2014-03-01

4.  The role of intracellular trafficking and the VPS10d receptors in Alzheimer's disease.

Authors:  Christiane Reitz
Journal:  Future Neurol       Date:  2012-07-01

Review 5.  The Role of SORL1 in Alzheimer's Disease.

Authors:  Rui-Hua Yin; Jin-Tai Yu; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-05-16       Impact factor: 5.590

6.  Y682G Mutation of Amyloid Precursor Protein Promotes Endo-Lysosomal Dysfunction by Disrupting APP-SorLA Interaction.

Authors:  Luca Rosario La Rosa; Lorena Perrone; Morten Schallburg Nielsen; Pietro Calissano; Olav Michael Andersen; Carmela Matrone
Journal:  Front Cell Neurosci       Date:  2015-04-07       Impact factor: 5.505

7.  SORL1 gene, plasma biomarkers, and the risk of Alzheimer's disease for the Han Chinese population in Taiwan.

Authors:  Cheng-Ta Chou; Yi-Chu Liao; Wei-Ju Lee; Shuu-Jiun Wang; Jong-Ling Fuh
Journal:  Alzheimers Res Ther       Date:  2016-12-30       Impact factor: 6.982

8.  LRP-1 polymorphism is associated with global and regional amyloid load in Alzheimer's Disease in humans in-vivo.

Authors:  Timo Grimmer; Oliver Goldhardt; Liang-Hao Guo; Behrooz H Yousefi; Stefan Förster; Alexander Drzezga; Christian Sorg; Panagiotis Alexopoulos; Hans Förstl; Alexander Kurz; Robert Perneczky
Journal:  Neuroimage Clin       Date:  2014-02-05       Impact factor: 4.881

9.  Tetraspanin CD9 modulates ADAM17-mediated shedding of LR11 in leukocytes.

Authors:  Shokichi Tsukamoto; Masahiro Takeuchi; Takeharu Kawaguchi; Emi Togasaki; Atsuko Yamazaki; Yasumasa Sugita; Tomoya Muto; Shio Sakai; Yusuke Takeda; Chikako Ohwada; Emiko Sakaida; Naomi Shimizu; Keigo Nishii; Meizi Jiang; Koutaro Yokote; Hideaki Bujo; Chiaki Nakaseko
Journal:  Exp Mol Med       Date:  2014-04-04       Impact factor: 8.718

10.  Effect of Alzheimer's Disease Risk Variant rs3824968 at SORL1 on Regional Gray Matter Volume and Age-Related Interaction in Adult Lifespan.

Authors:  Chu-Chung Huang; Mu-En Liu; Hung-Wen Kao; Kun-Hsien Chou; Albert C Yang; Ying-Hsiu Wang; Tong-Ru Chen; Shih-Jen Tsai; Ching-Po Lin
Journal:  Sci Rep       Date:  2016-03-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.